285 related articles for article (PubMed ID: 19234858)
1. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.
Weller RO; Boche D; Nicoll JA
Acta Neuropathol; 2009 Jul; 118(1):87-102. PubMed ID: 19234858
[TBL] [Abstract][Full Text] [Related]
2. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.
Weller RO; Subash M; Preston SD; Mazanti I; Carare RO
Brain Pathol; 2008 Apr; 18(2):253-66. PubMed ID: 18363936
[TBL] [Abstract][Full Text] [Related]
3. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy.
Hawkes CA; Jayakody N; Johnston DA; Bechmann I; Carare RO
Brain Pathol; 2014 Jul; 24(4):396-403. PubMed ID: 24946077
[TBL] [Abstract][Full Text] [Related]
4. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.
Preston SD; Steart PV; Wilkinson A; Nicoll JA; Weller RO
Neuropathol Appl Neurobiol; 2003 Apr; 29(2):106-17. PubMed ID: 12662319
[TBL] [Abstract][Full Text] [Related]
5. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.
Weller RO; Nicoll JA
Neurol Res; 2003 Sep; 25(6):611-6. PubMed ID: 14503015
[TBL] [Abstract][Full Text] [Related]
6. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
Haglund M; Kalaria R; Slade JY; Englund E
Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
[TBL] [Abstract][Full Text] [Related]
7. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO
Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683
[TBL] [Abstract][Full Text] [Related]
8. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.
Keable A; Fenna K; Yuen HM; Johnston DA; Smyth NR; Smith C; Al-Shahi Salman R; Samarasekera N; Nicoll JA; Attems J; Kalaria RN; Weller RO; Carare RO
Biochim Biophys Acta; 2016 May; 1862(5):1037-46. PubMed ID: 26327684
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
10. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy.
Hawkes CA; Härtig W; Kacza J; Schliebs R; Weller RO; Nicoll JA; Carare RO
Acta Neuropathol; 2011 Apr; 121(4):431-43. PubMed ID: 21259015
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.
Weller RO; Yow HY; Preston SD; Mazanti I; Nicoll JA
Ann N Y Acad Sci; 2002 Nov; 977():162-8. PubMed ID: 12480747
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.
Nicoll JA; Yamada M; Frackowiak J; Mazur-Kolecka B; Weller RO
Neurobiol Aging; 2004; 25(5):589-97; discussion 603-4. PubMed ID: 15172734
[TBL] [Abstract][Full Text] [Related]
13. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.
Roher AE; Kuo YM; Esh C; Knebel C; Weiss N; Kalback W; Luehrs DC; Childress JL; Beach TG; Weller RO; Kokjohn TA
Mol Med; 2003; 9(3-4):112-22. PubMed ID: 12865947
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.
Weller RO; Cohen NR; Nicoll JA
Panminerva Med; 2004 Dec; 46(4):239-51. PubMed ID: 15876980
[TBL] [Abstract][Full Text] [Related]
15. A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.
Zabel M; Schrag M; Crofton A; Tung S; Beaufond P; Van Ornam J; Dininni A; Vinters HV; Coppola G; Kirsch WM
Brain Pathol; 2013 Jul; 23(4):390-401. PubMed ID: 23134465
[TBL] [Abstract][Full Text] [Related]
16. High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease.
Soontornniyomkij V; Choi C; Pomakian J; Vinters HV
Hum Pathol; 2010 Nov; 41(11):1601-8. PubMed ID: 20688356
[TBL] [Abstract][Full Text] [Related]
17. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
18. The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.
Kövari E; Herrmann FR; Hof PR; Bouras C
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):498-509. PubMed ID: 23163235
[TBL] [Abstract][Full Text] [Related]
19. Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy.
Sakai K; Boche D; Carare R; Johnston D; Holmes C; Love S; Nicoll JA
Acta Neuropathol; 2014 Dec; 128(6):777-89. PubMed ID: 25195061
[TBL] [Abstract][Full Text] [Related]
20. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
